By Barrie av / Mar, 22 2024
GlaxoSmithKline and Ranbaxy Reach Settlement on Valacyclovir U.S. Patent Litigation: Impacts and Insights
GlaxoSmithKline and Ranbaxy have reached an agreement to settle the U.S. patent litigation concerning valacyclovir. This move not only concludes years of legal disputes but also highlights the complexities surrounding patent laws in the pharmaceutical sector. The settlement could have wider implications for generic drug availability and healthcare costs.
view more